All Curated Mutation Sites in HPV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HPV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
E1
  
E1^E4
  
E2
  
E5
  
E6
  
E7
  
L1
  
L2
  

Keyword: Papillomavirus Infections-30583025
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 30583025 A4166G
L2
L2
Papillomavirus Infections
G
R
S
L
View
2 30583025 A4407G
L2
L2
Papillomavirus Infections
G
R
S
L
View
3 30583025 A4692T
L2
L2
Papillomavirus Infections
G
R
S
L
View
4 30583025 A5160C
L2
L2
Papillomavirus Infections
G
R
S
L
View
5 30583025 A5335C
L2
L2
Papillomavirus Infections
G
R
S
L
View
6 30583025 C4566A
L2
L2
Papillomavirus Infections
G
R
S
L
View
7 30583025 C4695T
L2
L2
Papillomavirus Infections
G
R
S
L
View
8 30583025 C4830T
L2
L2
Papillomavirus Infections
G
R
S
L
View
9 30583025 C4985A
L2
L2
Papillomavirus Infections
G
R
S
L
View
10 30583025 D271N
L2
L2
Papillomavirus Infections
G
R
S
L
View
11 30583025 E109D
L2
L2
Papillomavirus Infections
G
R
S
L
View
12 30583025 G4227A
L2
L2
Papillomavirus Infections
G
R
S
L
View
13 30583025 G4229A
L2
L2
Papillomavirus Infections
G
R
S
L
View
14 30583025 G4283A
L2
L2
Papillomavirus Infections
G
R
S
L
View
15 30583025 G4424A
L2
L2
Papillomavirus Infections
G
R
S
L
View
16 30583025 G4461A
L2
L2
Papillomavirus Infections
G
R
S
L
View
17 30583025 G4461C
L2
L2
Papillomavirus Infections
G
R
S
L
View
18 30583025 G4839A
L2
L2
Papillomavirus Infections
G
R
S
L
View
19 30583025 G4945A
L2
L2
Papillomavirus Infections
G
R
S
L
View
20 30583025 I92V
L2
L2
Papillomavirus Infections
G
R
S
L
View
21 30583025 L376V
L2
L2
Papillomavirus Infections
G
R
S
L
View
22 30583025 T284K
L2
L2
Papillomavirus Infections
G
R
S
L
View
23 30583025 T401P
L2
L2
Papillomavirus Infections
G
R
S
L
View
24 30583025 T4453C
L2
L2
Papillomavirus Infections
G
R
S
L
View
25 30583025 T4596C
L2
L2
Papillomavirus Infections
G
R
S
L
View
26 30583025 T4672C
L2
L2
Papillomavirus Infections
G
R
S
L
View
27 30583025 T5260G
L2
L2
Papillomavirus Infections
G
R
S
L
View
28 30583025 T5286G
L2
L2
Papillomavirus Infections
G
R
S
L
View
29 30583025 V32I
L2
L2
Papillomavirus Infections
G
R
S
L
View
30 30583025 A5649T
L1
L1
Papillomavirus Infections
G
R
S
L
View
31 30583025 A5674C
L1
L1
Papillomavirus Infections
G
R
S
L
View
32 30583025 A6047G
L1
L1
Papillomavirus Infections
G
R
S
L
View
33 30583025 A6312T
L1
L1
Papillomavirus Infections
G
R
S
L
View
34 30583025 A6328G
L1
L1
Papillomavirus Infections
G
R
S
L
View
35 30583025 A6335C
L1
L1
Papillomavirus Infections
G
R
S
L
View
36 30583025 A6435G
L1
L1
Papillomavirus Infections
G
R
S
L
View
37 30583025 A6586C
L1
L1
Papillomavirus Infections
G
R
S
L
View
38 30583025 A6651G
L1
L1
Papillomavirus Infections
G
R
S
L
View
39 30583025 A6784C
L1
L1
Papillomavirus Infections
G
R
S
L
View
40 30583025 A6882G
L1
L1
Papillomavirus Infections
G
R
S
L
View
41 30583025 C6147T
L1
L1
Papillomavirus Infections
G
R
S
L
View
42 30583025 C6918A
L1
L1
Papillomavirus Infections
G
R
S
L
View
43 30583025 G265S
L1
L1
Papillomavirus Infections
G
R
S
L
View
44 30583025 G6313A
L1
L1
Papillomavirus Infections
G
R
S
L
View
45 30583025 G6570A
L1
L1
Papillomavirus Infections
G
R
S
L
View
46 30583025 G6984A
L1
L1
Papillomavirus Infections
G
R
S
L
View
47 30583025 I270V
L1
L1
Papillomavirus Infections
G
R
S
L
View
48 30583025 I52L
L1
L1
Papillomavirus Infections
G
R
S
L
View
49 30583025 N176S
L1
L1
Papillomavirus Infections
G
R
S
L
View
50 30583025 N272T
L1
L1
Papillomavirus Infections
G
R
S
L
View
51 30583025 S487P
L1
L1
Papillomavirus Infections
G
R
S
L
View
52 30583025 T354P
L1
L1
Papillomavirus Infections
G
R
S
L
View
53 30583025 T6311G
L1
L1
Papillomavirus Infections
G
R
S
L
View
54 30583025 T6774C
L1
L1
Papillomavirus Infections
G
R
S
L
View
55 30583025 T6979C
L1
L1
Papillomavirus Infections
G
R
S
L
View
56 30583025 V264G
L1
L1
Papillomavirus Infections
G
R
S
L
View
57 30583025 A832G
E7
E7
Papillomavirus Infections
G
R
S
L
View
58 30583025 C395T
E7
E7
Papillomavirus Infections
G
R
S
L
View
59 30583025 C756T
E7
E7
Papillomavirus Infections
G
R
S
L
View
60 30583025 C796T
E7
E7
Papillomavirus Infections
G
R
S
L
View
61 30583025 S100L
E7
E7
Papillomavirus Infections
G
R
S
L
View
62 30583025 S66L
E7
E7
Papillomavirus Infections
G
R
S
L
View
Contents
Description

The table shows all curated mutation sites of HPV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.